Pegylated liposmal doxorubicin prolongs survival compared to topotecan as second-line treatment in women with platinum-sensitive ovarian cancer
- Resource Type
- Source
- Evidence-based Oncology. 3:21-23
- Subject
Oncology medicine.medical_specialty Second line treatment business.industry medicine.disease Internal medicine medicine Doxorubicin Topotecan Platinum sensitive Ovarian cancer business medicine.drug - Language
- ISSN
- 1363-4054